## FIVN: Five9, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.70 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($18.77)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. VP Kozanian Files To Sell 10,858 Of Five9 Inc [FIVN]**
- Source: TradingView | 20251205T051057 | Neutral | Relevance: 100%
- VP Panos Kozanian of Five9 Inc [FIVN] filed a Form 144 on December 4, 2025, proposing to sell 10,858 shares of restricted securities through Morgan Stanley Smith Barney LLC. This sale is being executed pursuant to a prearranged trading plan (10b5-1). The Washington Service, founded in 1970, provides financial and economic research, and offers services related to insider trading analysis and data.

**2. Five9 (FIVN): Reassessing Valuation After Strong Enterprise AI Growth and Expanded Leadership Bench**
- Source: Simply Wall Street | 20251205T035139 | Somewhat-Bullish | Relevance: 100%
- Five9 (FIVN) is approaching the UBS Global Technology and AI Conference with a mix of challenges and opportunities, marked by its stock price decline in 2025 but recent gains suggesting a potential reassessment of its AI-driven growth. The company is considered undervalued by some narratives, with a fair value of $34.05, citing strong Enterprise AI revenue growth of 42% and AI bookings representing over 20% of new ACV. However, the article also flags a “very different picture” on valuation due to its high P/E ratio compared to industry peers, indicating potential downside risk.

**3. Lumbard & Kellner LLC Reduces Position in Five9, Inc. $FIVN**
- Source: MarketBeat | 20251203T054101 | Neutral | Relevance: 100%
- Lumbard & Kellner LLC reduced its stake in Five9, Inc. by 16.8% in Q2, while other institutional investors like Ameriprise Financial Inc. and UBS AM increased their holdings. Despite the reduction by one firm, institutional investors collectively own 96.64% of Five9's stock. The company's board has authorized a $50 million share buyback, and analysts maintain a "Moderate Buy" consensus with a target price of $35.19.

**4. Five9 CRO Tuckness sells $106939 in FIVN stock**
- Source: Investing.com | 20251205T051057 | Neutral | Relevance: 90%
- Five9's Chief Revenue Officer, Matthew E. Tuckness, sold 5,255 shares of FIVN stock for $106,939 to cover tax obligations. This transaction leaves him with 176,379 shares. The sale follows a strong Q3 2025 earnings report for Five9, though analysts like Cantor Fitzgerald and DA Davidson have adjusted their price targets due to growth concerns.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-07 | Wells Fargo | $22 | $28 | -21% |
| 2025-11-07 | Cantor Fitzgera | $32 | $36 | -11% |
| 2025-11-07 | Barclays | $29 | $33 | -12% |
| 2025-11-07 | Piper Sandler | $26 | $31 | -16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-07 | Wells Fargo | main | Equal-Weight |
| 2025-11-07 | Cantor Fitzgera | main | Overweight |
| 2025-11-07 | Barclays | main | Overweight |
| 2025-11-07 | Piper Sandler | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 10 ($1.13M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Blackrock Inc.: 9.0% (-2.1%)
- Pictet Asset Managem: 7.7% (+6.4%)
- Voss Capital, LP: 5.8% (+40.0%)
- FMR, LLC: 5.0% (-31.4%)

### Key Risks

1. Elevated short interest (12.5%): bears positioning against stock.
2. Long-term trend broken: trading 20.4% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +5.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.70 indicates undervaluation relative to growth. Forward P/E 6.5x attractive for 8% earnings growth. Balance sheet: strong liquidity (4.2x). Analyst sentiment negative (4 target cuts vs 0 raises). Insider selling cluster ($1.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1.6B |
| Beta | 1.36 |
| 52W Range | $17.71 - $49.90 |
| Short Interest | 12.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.70 |
| Forward P/E | 6.5 |
| Current P/E | 7.0 |
| YoY Growth | 8.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -2.6% to 2.5% (+5.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.5pp (needs >4.0% for momentum thesis). MRS_5 at 1.3% confirms short-term momentum alignment. AM_20 at 4.8% shows strong absolute momentum above own 20MA. Below SMA200 (0.80x), long-term trend not supportive. RSI neutral at 51. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.49% (CS: 71) | Neutral |
| RSI_14 | 50.8 | Neutral |
| MACD Histogram | 0.31 | Bullish |
| vs SMA20 | 1.048x | Above |
| vs SMA50 | 0.954x | Below |
| vs SMA200 | 0.796x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $20.65
- **Stop Loss:** $18.77 (9.1% risk)
- **Target:** $24.41 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 531
- **Position Value:** $10,965.15
- **Portfolio %:** 10.97%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-19 (Est: $0.78)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.73 | $0.78 | +6.5% |
| 2025Q2 | $0.65 | $0.76 | +17.0% |
| 2025Q1 | $0.48 | $0.62 | +28.4% |
| 2024Q4 | $0.70 | $0.79 | +12.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*